NCT04049227 2025-10-20
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
Clinical Trials
12 trialsNCT02730429 2025-07-31
Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 2 Completed
NCT03378297 2024-10-30
IMPACT
Haukeland University Hospital
Phase EARLY_PHASE1 Completed
NCT03936270 2024-02-20
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer
Latin American Cooperative Oncology Group
Phase 2 Completed
NCT01999569 2022-04-22
The Role of Estrogen in Luteinizing Hormone Surge and Ovulation
Wake Forest University Health Sciences
Phase 4 Completed
NCT02657928 2021-10-26
Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer
Mayo Clinic
Phase 2 Completed
NCT02283658 2020-10-23
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Mayo Clinic
Phase 2 Completed
NCT00004251 2020-04-06
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT03285802 2020-02-05
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
Greater Baltimore Medical Center
Phase 2/3 Completed
NCT00997373 2017-05-30
Letrozole as a Treatment of Endometrial Cancer
University of California, Davis
Phase NA Completed
NCT00171808 2016-11-18
deFEND
Novartis
Phase 2 Completed
NCT00333086 2012-04-19
A Study of Letrozole in the Treatment of Endometrial Cancer
Novartis
Phase 2 Completed